RECOMBINANT VIRUS EXPRESSING CARCINOEMBRYONIC ANTIGEN AND METHODS OF USE THEREOF
The present invention relates to a recombinant carcinoembryonic antigen (CEA)/vaccinia virus or other viral vector which expresses GEA on the surface of infected cells and which elicits an immune response in vivo directed against CEA or cells ex- pressing CEA an d a pharmaceutical composition contai...
Saved in:
Main Authors | , |
---|---|
Format | Patent |
Language | English French |
Published |
07.11.1992
|
Edition | 5 |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The present invention relates to a recombinant carcinoembryonic antigen (CEA)/vaccinia virus or other viral vector which expresses GEA on the surface of infected cells and which elicits an immune response in vivo directed against CEA or cells ex- pressing CEA an d a pharmaceutical composition containing same. The inventio n also relates to methods of treating patients con- taining carcinoma cells in which CEA is expressed and methods of stimulating the immune system against CEA.
2102623 9219266 PCTABS00017 The present invention relates to a recombinant carcinoembryonic antigen (CEA)/vaccinia virus or other viral vector which expresses CEA on the surface of infected cells and which elicits an immune response in vivo directed against CEA or cells expressing CEA an d a pharmaceutical composition containing same. The invention also relates to methods of treating patients containing carcinoma cells in which CEA is expressed and methods of stimulating the immune system against CEA. |
---|---|
Bibliography: | Application Number: CA19922102623 |